Mild Cognitive Impairment Clinical Trial
Official title:
Efficacy of Computerized Cognitive Training in the Elderly With Mild Cognitive Impairment: Clinical Outcomes and Magnetoencephalographic Imaging
Mild cognitive impairment (MCI) is the prodrome of the cognitive function declining before
Alzheimer's disease or other dementia showed up, the impairments of language, visuospatial
relationship, attention, and memory included and instrumental activities of daily living
(IADL) influenced. MCI is considered as a transitional stage between normal aging and mild
dementia, and the patients with MCI has differently fluctuated cognitive functions in a
period of time, such as from normal cognition to MCI or developing to dementia. The annual
conversion rate (ACR) of older adults with normal cognition developed to MCI is 30%, and 5%
in clinical setting, and community, respectively. Not all of patients with MCI develop to
Alzheimer's disease, the reversion of patients with MCI to normal cognition exists. However,
MCI is a significant risk factor. The ACR of older adults with normal cognition or MCI
developed to dementia is 1-2%, and 5-15%, respectively; moreover, about half of patients with
MCI developed to dementia in 5 years.
Cognitive training (CT) improves cognitive functions with repetitive practicing standardized
cognitive tasks of specific cognitive functions, such as memory, attention, or problem
solving. CT has widely defined including strategy training, in which contained cognitive
exercise, strategy indicating and practicing to reducing cognitive impairments and improving
performances. CT is more effective for MCI. Recently, computer-based CT (CCT) with many
advantages gradually replaced the traditional paper-pencil form. Brief systematic review
showed that the computer-based intervention had positive effects on behavioral symptoms, such
as depression and anxiety, in patients with MCI and/or dementia. Previous studies
demonstrated that computer-based intervention exhibited moderate treatment effects on overall
cognitive functions in patients with MCI, and also had positive effects on learning,
short-term memory, and behavioral symptoms.
Older people with cognitive impairments is expected to increase by global aging. It is
important for improving or maintaining cognitive functions of older adults with MCI. The
efficacy of the CCT on cognitive functions, neuropsychiatric symptoms, daily functions, and
brain activated imaging of the magnetoencephalography (MEG) of in older adults with MCI is
worth to explore for busy clinical practice.
The study design was a prospective and single-blinded randomized controlled trial. 36
participants with MCI were recruited and demographic data (age, gender, education level
/years of education, marriage status etc.) were also collected. The MCI participants
underwent the comprehensive review at baseline including neuropsychological assessment and
Magnetic Resonance Imaging or Computerized Tomogram. Randomization treatment assignment will
be generated by the random number table and assign the patient's intervention group
accordingly. Sealed opaque envelopes containing the CCT group, or the dosage-matched control
group sheets will be prepared and given to the therapists.
Based on the t-test effect size of index d 1.00 indicates, an estimated 17 participants in
each group will be required for a power of 0.80 with a two-sided type I error of 0.05.
Considering the 5% (q) drop rate, we will need to recruit 18 participants (N/1-q) for each
group. The participants were randomly allocated to either the CCT group (18 participants) or
the dosage-matched control group (18 participants) with individualized intervention for 30
minutes a day, 3 times a week for 4 consecutive weeks. Clinical outcome measures, and the
imaging of the MEG were administered at pre- treatment, post-treatment and 1-month follow-up
for further analysis.
Statistical analysis was performed using Statistical Package for the Social Sciences (SPSS)
version 19.0. In statistical testing, two-sided p value ≤ 0.05 was considered statistically
significant. The distributional properties of continuous variables were expressed by mean ±
standard deviation (SD), categorical variables were presented by frequency and percentage.
The differences in the distributions of continuous variables, categorical variables between
the treatment and control groups were examined using two-sample t-test, Wilcoxon rank-sum
test (or Mann-Whitney U test), and chi-square test. In addition, the minimum norm estimates
(MNE), source-based time-frequency analysis, cross-frequency coupling, and functional
connectivity were used to explore the differences of the activation of brain functions in
participants between different treatment groups. The t-test was used to explore the
differences of reaction time, rate of correction, and physical signals in stimulus reaction
test of the MEG between in participants between different treatment groups. The correlation
statistics was used to explore relationships between the scores of outcome measurements and
the physical signals.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04513106 -
Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial
|
N/A | |
Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Active, not recruiting |
NCT03167840 -
Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment
|
N/A | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Not yet recruiting |
NCT05041790 -
A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
|
Phase 4 | |
Recruiting |
NCT04121156 -
High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment
|
N/A | |
Recruiting |
NCT03605381 -
MORbidity PRevalence Estimate In StrokE
|
||
Completed |
NCT02774083 -
Cognitive Training Using Feuerstein Instrumental Enrichment
|
N/A | |
Completed |
NCT01315639 -
New Biomarker for Alzheimer's Disease Diagnostic
|
N/A | |
Enrolling by invitation |
NCT06023446 -
Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
|
||
Completed |
NCT04567745 -
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers
|
Phase 1 | |
Recruiting |
NCT05579236 -
Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
|
||
Completed |
NCT03583879 -
Using Gait Robotics to Improve Symptoms of Parkinson's Disease
|
N/A | |
Terminated |
NCT02503501 -
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
|
Phase 2 | |
Not yet recruiting |
NCT03740178 -
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
|
Phase 1 | |
Active, not recruiting |
NCT05204940 -
Longitudinal Observational Biomarker Study
|
||
Recruiting |
NCT02663531 -
Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Recruiting |
NCT03507192 -
Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia.
|
N/A |